J B Chemicals & Pharmaceuticals Ltd, founded in 1976 and headquartered in Mumbai, Maharashtra, is one of India’s leading pharmaceutical companies. The organization has established a robust presence in the pharmaceutical industry with a comprehensive portfolio that includes pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (APIs). Their product offerings encompass various dosage forms such as tablets, injectables, creams, ointments, lozenges, herbal liquids, and capsules. Additionally, the company is recognized for its value-added services, including formulation optimization, scale-up services, stability testing, regulatory support, packaging design, and commercial production. Guided by a strong leadership team, including CEO Nikhil Ashokkumar Chopra, CFO Narayan Saraf, and Assistant Vice President of HR Suresh Amin, the company has gained trust in both domestic and international markets under its stock symbol JBCHEPHARM and ISIN INE572A01036.
Globally, J B Chemicals & Pharmaceuticals focuses on diverse therapeutic areas such as gastroenterology, neonatology, pediatrics, gynaecology, dental care, hypertension, diabetes, nephrology, respiratory care, dermatology, and antivirals, among others. The company’s commitment to quality and innovation is reflected in its ongoing investment in research and development, ensuring the delivery of high-quality, effective solutions. Furthermore, it emphasizes customer satisfaction and sustainability, striving to meet customer needs while promoting environmental stewardship and community well-being. Through these efforts, the company has positioned itself as a trusted name in the pharmaceutical industry, with a reputation for excellence and a commitment to improving global health outcomes.
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | |
| Promoters + | 53.86% | 53.83% | 53.78% | 53.77% | 53.74% |
| FIIs + | 10.05% | 10.35% | 11.06% | 12.17% | 13.63% |
| DIIs + | 18.58% | 18.53% | 18.38% | 17.61% | 16.81% |
| Government + | 0.00% | 0.00% | 0.01% | 0.00% | 0.01% |
| Public + | 17.50% | 17.27% | 16.78% | 16.42% | 15.80% |
| No. of Shareholders | 60,817 | 63,230 | 63,892 | 66,953 | 62,743 |
The shareholding pattern of J B Chemicals & Pharmaceuticals Ltd from September 2023 to September 2024 reflects notable trends across various stakeholder categories. Promoters consistently held a majority stake, slightly decreasing from 53.86% in September 2023 to 53.74% in September 2024, indicating stable ownership. Foreign Institutional Investors (FIIs) significantly increased their holdings, rising from 10.05% to 13.63%, showcasing growing foreign investor confidence. In contrast, Domestic Institutional Investors (DIIs) reduced their stake from 18.58% to 16.81%, and public shareholding also declined from 17.50% to 15.80%, suggesting a shift in ownership towards institutional stakeholders. The Government’s participation remained minimal, with a nominal 0.01% share in March and September 2024. Additionally, the number of shareholders fluctuated, peaking at 66,953 in June 2024 before settling at 62,743 in September 2024, highlighting dynamic investor engagement with J B Chemicals & Pharmaceuticals Ltd.
Below are the trading platforms that you can use to purchase J B Chemicals & Pharmaceuticals shares:
➤ Zerodha
➤ Upstox
➤ Groww
➤ AngelOne
➤ ICICIDirect
| When | Maximum Price | Minimum Price |
| January 2025 | 1,902.05 | 1,463.12 |
| February 2025 | 1,921.27 | 1,477.90 |
| March 2025 | 1,961.61 | 1,508.93 |
| April 2025 | 1,942.19 | 1,493.99 |
| May 2025 | 1,885.62 | 1,450.48 |
| June 2025 | 1,970.48 | 1,515.75 |
| July 2025 | 1,931.84 | 1,486.03 |
| August 2025 | 1,991.59 | 1,531.99 |
| September 2025 | 2,015.49 | 1,550.37 |
| October 2025 | 2,067.89 | 1,590.68 |
| November 2025 | 2,119.59 | 1,630.45 |
| December 2025 | 2,214.97 | 1,703.82 |
As we step into 2025, the maximum price of J B Chemicals & Pharmaceuticals is projected to begin at ₹1,902.05 in January, with a minimum of ₹1,463.12. Throughout the year, the company’s stock prices are expected to show a steady upward trend, reflecting its tremendous market performance and investor confidence. By December 2025, the maximum price is anticipated to reach ₹2,214.97, with a minimum of ₹1,703.82. This consistent growth highlights the company’s potential for delivering strong returns and maintaining its leadership in the pharmaceutical sector.
| When | Maximum Price | Minimum Price |
| January 2026 | 2,281.42 | 1,754.94 |
| February 2026 | 2,224.38 | 1,711.06 |
| March 2026 | 2,268.87 | 1,745.28 |
| April 2026 | 2,315.17 | 1,780.90 |
| May 2026 | 2,292.25 | 1,763.27 |
| June 2026 | 2,349.56 | 1,807.35 |
| July 2026 | 2,303.49 | 1,771.91 |
| August 2026 | 2,374.73 | 1,826.71 |
| September 2026 | 2,422.22 | 1,863.25 |
| October 2026 | 2,485.20 | 1,911.69 |
| November 2026 | 2,547.33 | 1,959.48 |
| December 2026 | 2,611.01 | 2,008.47 |
As we move into 2026, the maximum price of J B Chemicals & Pharmaceuticals is expected to commence at ₹2,281.42 in January, with a minimum of ₹1,754.94. The year is projected to witness a progressive increase in stock values, reflecting the company’s strong financial performance and market presence. By December 2026, the maximum price is anticipated to rise to ₹2,611.01, while the minimum price may reach ₹2,008.47.
| When | Maximum Price | Minimum Price |
| January 2027 | 2,637.12 | 2,028.56 |
| February 2027 | 2,704.74 | 2,080.57 |
| March 2027 | 2,810.23 | 2,161.71 |
| April 2027 | 2,755.12 | 2,119.33 |
| May 2027 | 2,674.88 | 2,057.60 |
| June 2027 | 2,795.25 | 2,150.19 |
| July 2027 | 2,740.44 | 2,108.03 |
| August 2027 | 2,825.19 | 2,173.23 |
| September 2027 | 2,924.08 | 2,249.29 |
| October 2027 | 3,000.10 | 2,307.77 |
| November 2027 | 3,075.10 | 2,365.46 |
| December 2027 | 3,151.98 | 2,424.60 |
| When | Maximum Price | Minimum Price |
| January 2028 | 3,215.02 | 2,473.09 |
| February 2028 | 3,297.46 | 2,536.51 |
| March 2028 | 3,426.06 | 2,635.43 |
| April 2028 | 3,358.88 | 2,583.75 |
| May 2028 | 3,261.05 | 2,508.50 |
| June 2028 | 3,407.80 | 2,621.38 |
| July 2028 | 3,340.98 | 2,569.98 |
| August 2028 | 3,444.31 | 2,649.47 |
| September 2028 | 3,564.86 | 2,742.20 |
| October 2028 | 3,657.54 | 2,813.50 |
| November 2028 | 3,748.98 | 2,883.83 |
| December 2028 | 3,842.71 | 2,955.93 |
| When | Maximum Price | Minimum Price |
| January 2029 | 3,919.56 | 3,015.05 |
| February 2029 | 4,020.06 | 3,092.36 |
| March 2029 | 4,176.85 | 3,212.96 |
| April 2029 | 4,094.95 | 3,149.96 |
| May 2029 | 3,975.68 | 3,058.21 |
| June 2029 | 4,154.58 | 3,195.83 |
| July 2029 | 4,073.12 | 3,133.17 |
| August 2029 | 4,199.09 | 3,230.07 |
| September 2029 | 4,346.06 | 3,343.12 |
| October 2029 | 4,459.06 | 3,430.04 |
| November 2029 | 4,570.53 | 3,515.80 |
| December 2029 | 4,684.80 | 3,603.69 |
| When | Maximum Price | Minimum Price |
| January 2030 | 4,778.49 | 3,675.76 |
| February 2030 | 4,901.02 | 3,770.01 |
| March 2030 | 5,092.16 | 3,917.04 |
| April 2030 | 4,992.31 | 3,840.24 |
| May 2030 | 4,846.90 | 3,728.39 |
| June 2030 | 5,065.02 | 3,896.17 |
| July 2030 | 4,965.70 | 3,819.77 |
| August 2030 | 5,119.28 | 3,937.91 |
| September 2030 | 5,298.45 | 4,075.73 |
| October 2030 | 5,436.21 | 4,181.70 |
| November 2030 | 5,572.12 | 4,286.25 |
| December 2030 | 5,711.42 | 4,393.40 |
As we go ahead into 2030, the maximum price of J B Chemicals & Pharmaceuticals is expected to start at ₹4,778.49 in January, with a minimum price of ₹3,675.76. The upward trend is likely to continue throughout the year, reflecting the company’s strong market position and growth potential. By December 2030, the maximum price is anticipated to climb to ₹5,711.42, while the minimum price may reach ₹4,393.40.
J B Chemicals & Pharmaceuticals Financial Condition
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
| Sales + | 1,775 | 2,043 | 2,424 | 3,149 | 3,484 | 3,711 |
| Expenses + | 1,397 | 1,482 | 1,881 | 2,454 | 2,587 | 2,739 |
| Operating Profit | 378 | 560 | 543 | 696 | 897 | 972 |
| OPM % | 21% | 27% | 22% | 22% | 26% | 26% |
| Other Income + | 41 | 112 | 39 | 10 | 37 | 40 |
| Interest | 3 | 7 | 5 | 36 | 44 | 30 |
| Depreciation | 66 | 69 | 73 | 114 | 138 | 157 |
| Profit before tax | 349 | 597 | 505 | 555 | 752 | 825 |
| Tax % | 22% | 25% | 24% | 26% | 26% | |
| Net Profit + | 272 | 449 | 386 | 410 | 553 | 611 |
| EPS in Rs | 17.6 | 28.98 | 24.93 | 26.48 | 35.61 | 39.37 |
| Dividend Payout % | 31% | 28% | 33% | 34% | 34% |
J B Chemicals & Pharmaceuticals Ltd has demonstrated remarkable financial growth and resilience over the past five years. The company’s sales have steadily increased from ₹1,775 crore in March 2020 to ₹3,484 crore in March 2024, further rising to ₹3,711 crore in the trailing twelve months (TTM). This consistent growth highlights the company’s ability to expand its market presence and maintain a strong revenue trajectory. Operating profit also showed significant improvement, climbing from ₹378 crore in March 2020 to ₹972 crore in TTM. The Operating Profit Margin (OPM) has remained robust, improving from 21% in 2020 to 26% in recent years, reflecting efficient cost management and operational strategies.
The company’s profitability metrics further underscore its financial strength. Net profit increased from ₹272 crore in March 2020 to ₹553 crore in March 2024 and reached ₹611 crore in TTM. This consistent rise in profits has translated into an impressive growth in Earnings Per Share (EPS), which surged from ₹17.6 in March 2020 to ₹39.37 in TTM. Despite rising expenses and depreciation, J B Chemicals & Pharmaceuticals Ltd has maintained healthy margins through strategic cost management and operational efficiency. Other income contributions and prudent financial practices have supported its ability to generate higher profits even amidst challenges.
The company’s commitment to rewarding its shareholders is evident from its steady dividend payouts, consistently around 34% in recent years. This reflects a balance between retaining earnings for growth and providing returns to investors. J B Chemicals & Pharmaceuticals Ltd’s focus on sustainable growth, coupled with its strong financial performance, positions it as a leader in the pharmaceutical industry. Its ability to consistently grow revenues, manage expenses, and enhance profitability highlights its strong financial foundation and growth-oriented approach.
FAQs
Will J B Chemicals & Pharmaceuticals stock price grow in 2025?
Yes, J B Chemicals & Pharmaceuticals stock price is expected to grow in 2025. The company’s current share price is around Rs 1,804, and analysts have estimated that J B Chemicals & Pharmaceuticals price is expected to reach ₹2,214.97 by the end of 2025.
What future is anticipated for J B Chemicals & Pharmaceuticals in 2026?
Analysts expect J B Chemicals & Pharmaceuticals stock price to reach Rs 2,611.01 by the end of 2026.
In 2030, J B Chemicals & Pharmaceuticals is expected to trade in between ₹3,675.76 and ₹5,711.42.
Also Read
- Greaves Cotton Share Price Target 2025, 2026 to 2030
- Techno Electric & Engineering Company Share Price Target 2025, 2026 to 2030
- Transport Corporation of India Share Price Target 2025, 2026 to 2030
Conclusion
In conclusion, J B Chemicals & Pharmaceuticals Ltd has shown significant growth in both operational performance and stock market potential. The company’s focus on expanding its reach across therapeutic areas, combined with its consistent innovation and global presence, positions it well for continued success. The shareholding patterns reveal a growing trust from institutional investors, especially from foreign institutional investors (FIIs), reflecting strong market confidence. Looking ahead, the company’s share price projections suggest a positive trend, with an estimated maximum price of ₹5,711.42 by December 2030. This indicates a promising future for J B Chemicals & Pharmaceuticals Ltd, driven by its solid market positioning and growth prospects.
Having said that, we are not a financial advisor. Please consult a SEBI-registered financial advisor before trading J B Chemicals & Pharmaceuticals. This post on J B Chemicals & Pharmaceuticals share price target from 2025 to 2030 is for educational purposes only.
What did we learn?
- 1 Shareholdings Patterns of J B Chemicals & Pharmaceuticals
- 2 How to Buy J B Chemicals & Pharmaceuticals shares?
- 3 J B Chemicals & Pharmaceuticals Share Price Target: 2025, 2026 to 2030
- 3.1 J B Chemicals & Pharmaceuticals Share Price Target 2025
- 3.2 J B Chemicals & Pharmaceuticals Share Price Target 2026
- 3.3 J B Chemicals & Pharmaceuticals Share Price Target 2027
- 3.4 J B Chemicals & Pharmaceuticals Share Price Prediction 2028
- 3.5 J B Chemicals & Pharmaceuticals Share Price Target 2029
- 3.6 J B Chemicals & Pharmaceuticals Share Price Prediction 2030
- 4 J B Chemicals & Pharmaceuticals Financial Condition
- 5 FAQs
- 6 Conclusion
